Showing results (261-270 of 301) with videos related to
Sort By:
Pageof 31
Pharmaceutical Medicine|December 6, 2016
Challenging Perceptions About Oncology Product Pricing in Breast and Colorectal CancerAnthony Barron, Tim WilsdonPharmaceutical Medicine|October 27, 2018
Development of New Formulations of Biologics: Expectations, Immunogenicity, and Safety for Subcutaneous TrastuzumabFranklin Fernandes Pimentel, Gilberto Morgan, Daniel Guimarães Tiezzi, et al.Pharmaceutical Medicine|July 24, 2022
Utilizing Deep Learning for Detecting Adverse Drug Events in Structured and Unstructured Regulatory Drug Data SetsBenjamin M Knisely, Qais Hatim, Monifa Vaughn-CookePharmaceutical Medicine|July 28, 2022
Are the Current Processes and Regulations Fit for Purpose to Deliver Novel Therapies During Pandemics? A Perspective on COVID-19 from the UKRajmeet Jandu, Carl Naraynassamy, Nadarajah SreeharanPharmaceutical Medicine|August 28, 2021
The Emergency Use Authorization of Pharmaceuticals: History and Utility During the COVID-19 PandemicAllan Tran, Theodore J WitekPharmaceutical Medicine|February 17, 2023
Clinical Presentations of Drug-Induced Hyperprolactinaemia: A Literature ReviewDaniela R Junqueira, Dimitri Bennett, Susanna Y Huh, et al.Pharmaceutical Medicine|February 14, 2023
Considerations for Effective Communication of Medical InformationEddie G M PowerPharmaceutical Medicine|March 4, 2025
Suggested Improvements to the Current East African Community Medicines Regulatory Harmonization Joint Review Process and a Proposed New Review Model for this InitiativeNancy Ngum, Chimwemwe Chamdimba, Dedith Mbonyingingo, et al.Pharmaceutical Medicine|March 3, 2025
Disproportionality Analysis and Causal Inference in Drug SafetyEmil Scosyrev, Sigrid Behr, Devendra Jain, et al.Pharmaceutical Medicine|February 22, 2025
Contraception Requirements in Early Clinical Trials: Considerations Towards an Evidence-Based ApproachTatyana Dubich, Ad F RoffelPageof 31